- Home
- REZI vs LEGN Comparison
REZI vs LEGN Comparison
Compare REZI & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REZI
- LEGN
- Stock Information
- Founded
- REZI 2018
- LEGN 2014
- Country
- REZI United States
- LEGN United States
- Employees
- REZI N/A
- LEGN N/A
- Industry
- REZI Wholesale Distributors
- LEGN Biotechnology: Pharmaceutical Preparations
- Sector
- REZI Industrials
- LEGN Health Care
- Exchange
- REZI Nasdaq
- LEGN Nasdaq
- Market Cap
- REZI 6.1B
- LEGN 6.3B
- IPO Year
- REZI N/A
- LEGN 2020
- Fundamental
- Price
- REZI $41.61
- LEGN $31.46
- Analyst Decision
- REZI Buy
- LEGN Strong Buy
- Analyst Count
- REZI 3
- LEGN 12
- Target Price
- REZI $34.67
- LEGN $73.36
- AVG Volume (30 Days)
- REZI 2.1M
- LEGN 1.2M
- Earning Date
- REZI 11-06-2025
- LEGN 11-11-2025
- Dividend Yield
- REZI N/A
- LEGN N/A
- EPS Growth
- REZI N/A
- LEGN N/A
- EPS
- REZI N/A
- LEGN N/A
- Revenue
- REZI $7,399,000,000.00
- LEGN $796,838,000.00
- Revenue This Year
- REZI $13.22
- LEGN $69.31
- Revenue Next Year
- REZI $3.40
- LEGN $52.73
- P/E Ratio
- REZI N/A
- LEGN N/A
- Revenue Growth
- REZI 20.00
- LEGN 74.75
- 52 Week Low
- REZI $14.18
- LEGN $27.34
- 52 Week High
- REZI $43.96
- LEGN $51.77
- Technical
- Relative Strength Index (RSI)
- REZI 64.44
- LEGN 31.45
- Support Level
- REZI $39.80
- LEGN $32.02
- Resistance Level
- REZI $43.96
- LEGN $32.62
- Average True Range (ATR)
- REZI 1.30
- LEGN 1.02
- MACD
- REZI -0.31
- LEGN -0.09
- Stochastic Oscillator
- REZI 45.98
- LEGN 6.87
About REZI Resideo Technologies Inc.
Resideo Technologies Inc is a manufacturer and developer of technology-driven products and components that provide critical comfort, energy management, and safety and security solutions. The company has two reportable segments; Products and Solutions segment offers temperature and humidity control, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety products, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions; and ADI Global Distribution segment includes wholesale distributor of low-voltage security products including access control, fire detection, security, and video products. It derives majority of its revenue from the United States.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.